Redirecting prescription drug rebates to offset Medicare Part D beneficiary cost sharing at the point-of-sale would boost government spending $43bn over 10 years, according to Congressional Budget Office projections.
The estimate was part of a set of cost and savings projections about provisions affecting Medicare in the President’s fiscal...






